81GyGuy said...
(IMHO, positive outlooks expressed in threads here are usually much more productive than negative ones).
81GyGuy, IMHO, insightful posts which are rich in depth & understanding—whether they are the popular or bravely contrarian position—are the most productive and meaningful of all, and appreciated by most…
81GyGuy said...
It would seem a safe assumption that their staff considered and debated the pros and cons of the "Man Van" concept, and eventually came down on the "let's do it" side.
This is not a personal jab, but that’s a really naïve assumption. The “Centre” is part of a “full service” medical facility, Rockyview General Hospital and the Southern Alberta Institute of Urology. They were the first hospital in Canada to own and operate a daVinci robot; now they have several and they need to keep them busy ($$). Don’t want surgery? No problem; they also have a menu of radiation options to zap you with. After treatment, they also offer services to work on improving your erectile dysfunction. Full Service. It’s a business. Like every for-profit and not-for-profit, they have a marketing function whose job it is to generate prospects.
The “man van” is a marketing campaign of mass screenings to bring in prospects. It’s naïve when people don’t realize that they are being marketed to (although it is effective marketing). But it even more naïve for men at a prostate cancer forum not to know and understand that this is exactly the reason behind the
landmark USPSTF decision giving a low grade (D) recommendation in 2012 (revised 2017)…to eliminate mass psa screenings in favor of an informed discussion/decision which we have today. There is not a professional medical society on earth today that supports the “man van” marketing tactic or mass screenings.
Want a little PC/marketing history? Of course you do. (I'll answer for you since you are reading but not responding to this thread.) The
first “PC Awareness Day” was organized in
1990 by a pharmaceutical company to “celebrate” the release of the very first anti-androgen drug, fultimide, which was for late-stage PC cases. In a ploy of marketing genius, the pharmaceutical’s newly organized “Awareness Day” included
promotion of the new PSA test because it would help to identify more patients and therefore maximize sales of the new drug (a.k.a. trolling for customers). This was, of course, roughly co-incident with Dr Patrick Walsh’s breakthrough “nerve-sparing” surgery technique which also helped to facilitate a "bloom" in the market and starting by the mid-90s “mass PSA screening” began aggressively pushing upstream to younger and younger patients, and finding more and more incidental varieties of PC.
By the 2000s, 80% of PC diagnosis were “organ confined,” yet there was absolutely no stigma attached to urologists rushing patients into life-altering aggressive treatment without regard to high-risk, intermediate-risk, or low-risk. In the early 2000s though, medical thought-leaders began speaking loudly in their professional societies against mass screenings and overtreatment. But appealing to the clinician’s to
do the right thing (stop overtreating) was ineffective, and it took the landmark USPSTF action in 2012 to finally squash (nearly) the practice of sending junior hematologists out from local hospitals to troll for customers at mass screenings at the mall, at work, at the race track, at the Y…or in a van. That USPSTF decision is a piece of PC history that we should all understand.
Post Edited (NKinney) : 2/6/2018 2:28:18 PM (GMT-7)